452.9000 -4.35 (-0.95%)
NSE Dec 24, 2025 15:31 PM
Volume: 215.0K
 

452.90
-0.95%
ICICI Securities Limited
Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.
Thyrocare Technologies Ltd. is trading below its 30 day SMA of 467.0
More from Thyrocare Technologies Ltd.
Recommended